SCHEMBL10011059

SCHEMBL10011059

CCCCOC(=O)CO[Si](C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.52
ALDH1A1 P00352 3/20 0.50
NAAA Q02083 1/20 0.50
HPGD P15428 2/20 0.48
TSHR P16473 2/20 0.48
HCAR2 Q8TDS4 2/20 0.46
DGKA P23743 1/20 0.45
NPSR1 Q6W5P4 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RAD52 P43351 1/20 0.43
FAAH O00519 1/20 0.42
HTR2C P28335 1/20 0.41
LMNA P02545 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29776772 0.88 ALDH1A1 (0.50) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL10011308 0.87 HCAR2 (0.42) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL21275447 0.80 ALDH1A1 (0.56) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL9791174 0.78 ALDH1A1 (0.54) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL195751 0.78 ALDH1A1 (0.54) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL3185929 0.78 ALDH1A1 (0.54) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL27388406 0.78 ALDH1A1 (0.54) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL1055702 0.78 ALDH1A1 (0.54) ATMALDH1A1NAAAHPGDTSHR
SCHEMBL10012033 0.78 GAA (0.52) ALDH1A1HPGDTSHRNPSR1LMNA
SCHEMBL22557919 0.78 ATM (0.50) ATMALDH1A1NAAAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 ATM 3398/4885ALDH1A1 2965/4885NAAA 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.